Atlanta Braves Holdings, Inc.·4

Feb 3, 4:05 PM ET

Robinson Jill L. 4

4 · Atlanta Braves Holdings, Inc. · Filed Feb 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Atlanta Braves (BATRK) CFO Jill L. Robinson Exercises Options and Sells Shares

What Happened
Jill L. Robinson, EVP, Chief Financial Officer & Treasurer of Atlanta Braves Holdings, exercised 20,000 derivative shares (options) at $27.18/share (cost $543,600) and the same day sold 20,000 common shares in an open-market transaction for roughly $40.00/share (proceeds ~$800,000). The Form 4 also reports a derivative disposition of 20,000 shares at $0 on the same date.

Key Details

  • Transaction date: 2026-02-02 (filed 2026-02-03; filing appears timely).
  • Exercise: 20,000 shares at $27.18 = $543,600 (code M).
  • Sale: 20,000 shares at a reported price of $40.00; filing lists weighted-average sale price range $39.71–$40.22 (footnote F2); proceeds shown as $800,000 (code S).
  • Additional derivative line: 20,000 share disposition at $0 reported (code M); the filing lists this separately in connection with the exercise.
  • Sale executed pursuant to a prearranged Rule 10b5-1 sales plan adopted May 15, 2025 (footnote F1).
  • Shares owned after the transactions: not specified in the filing.

Context
The sequence—exercising options and selling shares the same day—is commonly a cashless exercise or immediate sale of exercised shares; the reported 10b5-1 plan indicates the sale was prearranged. 10b5-1 sales are typically routine and do not by themselves imply a change in the insider’s view of the company. This filing does not indicate that Robinson is a 10% owner.

Insider Transaction Report

Form 4
Period: 2026-02-02
Robinson Jill L.
EVP, CFO & Treasurer
Transactions
  • Exercise/Conversion

    Series C Common Stock

    2026-02-02$27.18/sh+20,000$543,60099,460 total
  • Sale

    Series C Common Stock

    [F1][F2]
    2026-02-02$40.00/sh20,000$800,00079,460 total
  • Exercise/Conversion

    Stock option (Right to Buy) - BATRK

    2026-02-0220,00090,263 total
    Exercise: $27.18From: 2023-12-10Exp: 2027-12-10Series C Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2025.
  • [F2]Reflects the weighted average sale price. The range of prices for such transaction is $39.71 to $40.22. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
Signature
/s/ Greg Heller, Attorney-in-Fact|2026-02-03

Documents

1 file
  • 4
    form4-02032026_090252.xmlPrimary